Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Gastric Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 23 articles: HTML format

Single Articles

March 2026
1. JIN JJ, Dai FX, Long ZW, Cai H, et al
   [Corrigendum] CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
   Oncol Rep. 2026;55:38.
   PubMed     Abstract available
   
   
   
2. CONG N, Du P, Zhang A, Shen F, et al
   

   [Retracted] Downregulated microRNA?200a promotes EMT and tumor growth through the Wnt/beta?catenin pathway by targeting the E?cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma
   
   

   .
   Oncol Rep. 2026;55:40.
   PubMed     Abstract available
   
   
   
3. MU G, Li K, Hu C, Cai J, et al
   GPR176 enhances the epithelial?mesenchymal transition in gastric cancer cells by activating the PI3K/AKT/mTOR signaling pathway.
   Oncol Rep. 2026;55:48.
   PubMed     Abstract available
   
   
   January 2026
4. DU H, Hao XF, Lin BW, Zhang Y, et al
   Comparative analysis of the efficacy and safety of antibody?drug conjugates, radionuclide?drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatment.
   Oncol Rep. 2026;55:4.
   PubMed     Abstract available
   
   
   December 2025
5. YE YW, Hu S, Shi YQ, Zhang XF, et al
   [Expression of Concern] Combination of the FGFR4 inhibitor PD173074 and 5?fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
   Oncol Rep. 2025;54:171.
   PubMed     Abstract available
   
   
   November 2025
6. YUAN X, Zhang T, Zheng X, Zhang Y, et al
   [Corrigendum] Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.
   Oncol Rep. 2025;54:143.
   PubMed     Abstract available
   
   
   October 2025
7. ZHU X, Jia L, Kuai X, Tang Q, et al
   High expression of eIF4A1 promotes angiogenesis through the NF?kappaB/VEGFA pathway and predicts poor prognosis in gastric cancer.
   Oncol Rep. 2025;54:118.
   PubMed     Abstract available
   
   
   September 2025
8. LU S, Ma Y, Sun T, Ren R, et al
   [Retracted] Expression of alpha?fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.
   Oncol Rep. 2025;54:112.
   PubMed     Abstract available
   
   
   August 2025
9. GOMEZ-VALENZUELA F, Silva I, Retamal IN, Garcia-Bloj B, et al
   Comprehensive in?silico molecular analysis of early?onset gastric cancer identifies novel genes implicated in disease characterization and progression (Review).
   Oncol Rep. 2025;54:98.
   PubMed     Abstract available
   
   
   July 2025
10. QIU X, Pan T, Kuang T, Shen Y, et al
    DEPP1: A prognostic biomarker linked to stroma?rich and immunosuppressive microenvironment, promoting oxaliplatin resistance in gastric cancer.
    Oncol Rep. 2025;54:82.
    PubMed     Abstract available
    
    
    June 2025
11. CHEN P, Zhao D, Wang W, Zhang Y, et al
    [Corrigendum] High expression of RELM-alpha correlates with poor prognosis and promotes angiogenesis in gastric cancer.
    Oncol Rep. 2025;53:61.
    PubMed     Abstract available
    
    
    
12. LI Y, Wang K, Wei Y, Yao Q, et al
    [Retracted] lncRNA?MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR?29a?3p/HDAC4 axis.
    Oncol Rep. 2025;53:69.
    PubMed     Abstract available
    
    
    January 2025
13. YUN H, Dong F, Wei X, Yan X, et al
    Role and value of the tumor microenvironment in the progression and treatment resistance of gastric cancer (Review).
    Oncol Rep. 2025;53:14.
    PubMed     Abstract available
    
    
    October 2024
14. ZHU ZM, Li ZR, Huang Y, Yu HH, et al
    [Corrigendum] DJ?1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
    Oncol Rep. 2024;52:138.
    PubMed     Abstract available
    
    
    
15. XU G, Meng L, Yuan D, Li K, et al
    [Retracted] MEG3/miR?21 axis affects cell mobility by suppressing epithelial?mesenchymal transition in gastric cancer.
    Oncol Rep. 2024;52:140.
    PubMed     Abstract available
    
    
    August 2024
16. YAN H, Qiu C, Sun W, Gu M, et al
    [Retracted] Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.
    Oncol Rep. 2024;52:108.
    PubMed     Abstract available
    
    
    February 2024
17. WANG Y, Zhang H, Ge S, Fan Q, et al
    [Retracted] Effects of miR?138?5p and miR?204?5p on the migration and proliferation of gastric cancer cells by targeting EGFR.
    Oncol Rep. 2024;51:18.
    PubMed     Abstract available
    
    
    November 2023
18. GONG YC, Ren GL, Liu B, Li F, et al
    [Retracted] miR?206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
    Oncol Rep. 2023;50:197.
    PubMed     Abstract available
    
    
    October 2023
19. WANG JB, Jin Y, Wu P, Liu Y, et al
    [Corrigendum] Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells.
    Oncol Rep. 2023;50:187.
    PubMed     Abstract available
    
    
    July 2023
20. WANG L, Wu C, Xu J, Gong Z, et al
    GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via fatty acid oxidation metabolic reprogramming mediated by the miR‑5572/6855‑5p/CPT1A axis.
    Oncol Rep. 2023;50:138.
    PubMed     Abstract available
    
    
    May 2023
21. ZENG H, Wang J, Xu B, Deng H, et al
    Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma.
    Oncol Rep. 2023;49:88.
    PubMed     Abstract available
    
    
    
22. WANG H, Xiong M, Hu Y, Sun Y, et al
    [Retracted] MicroRNA‑19b inhibits proliferation of gastric cancer cells by targeting B‑cell CLL/lymphoma 3.
    Oncol Rep. 2023;49:104.
    PubMed     Abstract available
    
    
    April 2023
23. SUN DZ, Wei PK, Yue XQ
    Xiaotan Sanjie decoction normalizes tumor permissive microenvironment in gastric cancer (Review).
    Oncol Rep. 2023;49:74.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge.